As a Potential Predictor of Pan-Cancer, UBE2S is Related to Tumor-Associated Macrophage Infiltration
Future Oncology · 2023-09 · 19 (29) · 1961-1978
DOI: 10.2217/fon-2023-0086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Oncology, online erschienen am 04.10.2023. Verfasst von Haodi Yue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Center for Clinical Single Cell Biomedicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, …. Hauptthemen laut MEDLINE: Neoplasms, Tumor-Associated Macrophages. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: PhD research startup foundation of the Third Affiliated Hospital of Zhengzhou University.
Abstract (Originalsprache)
Background
At the pan-cancer level, exploring the expression and prognostic significance of a gene, such as UBE2S, will help to gain insight into the role of the gene and its feasibility for cancer screening, prognosis assessment and even gene therapy.
Methods
The Cancer Genome Atlas, Human Protein Atlas, Kaplan-Meier, Tumor Immunology Estimation Resource and other databases were used to analyze the expression of UBE2S at the pan-cancer level, its prognosis and the role of the immune microenvironment. Immunohistochemistry samples of tumor tissue collected in our clinic were taken as verification.
Results
UBE2S is significantly overexpressed in pan-cancer and is closely associated with malignant clinical features, poor prognosis and tumor-associated macrophages.
Conclusion
UBE2S may be a potential diagnostic and prognostic marker for pan-cancer and is associated with tumor-associated macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Center for Clinical Single Cell Biomedicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, Henan, China.
- Department of Orthopedics, Xuanwu Hospital, Capital Medical University, Beijing, 1000053, China.
- Department of Gynecology, Shijitan Hospital, Capital Medical University, Beijing, 1000038, China.
- Department of Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
ORCID-Profile: Haodi Yue, Jialin Wang, Siyu Hou, Mengjun Zhang
Förderung
- PhD research startup foundation of the Third Affiliated Hospital of Zhengzhou University
Zitieren
APA
Yue, H., Wang, J., Hou, S., & Zhang, M. (2023). As a Potential Predictor of Pan-Cancer, UBE2S is Related to Tumor-Associated Macrophage Infiltration. Future Oncology, 19(29), 1961-1978. https://doi.org/10.2217/fon-2023-0086
Vancouver
Yue H, Wang J, Hou S, Zhang M. As a Potential Predictor of Pan-Cancer, UBE2S is Related to Tumor-Associated Macrophage Infiltration. Future Oncology. 2023;19(29):1961-1978. doi:10.2217/fon-2023-0086
BibTeX
@article{Yue2023,
author = {Yue, Haodi and Wang, Jialin and Hou, Siyu and Zhang, Mengjun},
title = {As a Potential Predictor of Pan-Cancer, UBE2S is Related to Tumor-Associated Macrophage Infiltration},
journal = {Future Oncology},
year = {2023},
volume = {19},
number = {29},
pages = {1961--1978},
doi = {10.2217/fon-2023-0086}
}
EUVIMED